Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Treatment of postconcussional symptoms with CDP-choline.

Levin HS.

J Neurol Sci. 1991 Jul;103 Suppl:S39-42.

PMID:
1940965
2.

Effects of CDP-choline on the recovery of patients with head injury.

Calatayud Maldonado V, Calatayud Pérez JB, Aso Escario J.

J Neurol Sci. 1991 Jul;103 Suppl:S15-8.

PMID:
1940960
3.

CDP-choline: pharmacological and clinical review.

Secades JJ, Frontera G.

Methods Find Exp Clin Pharmacol. 1995 Oct;17 Suppl B:1-54. Review.

PMID:
8709678
4.

CDP-choline for the treatment of tardive dyskinesia: a small negative series.

Gelenberg AJ, Wojcik J, Falk WE, Bellinghausen B, Joseph AB.

Compr Psychiatry. 1989 Jan-Feb;30(1):1-4.

PMID:
2647398
5.

Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.

Alvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R.

Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):633-44.

PMID:
10669911
6.

Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease.

Franco-Maside A, Caamaño J, Gómez MJ, Cacabelos R.

Methods Find Exp Clin Pharmacol. 1994 Oct;16(8):597-607.

PMID:
7760585
7.

Age-related changes in memory and their pharmacologic modulation.

Agut J, Ortiz JA.

Ann N Y Acad Sci. 1991;640:295-7.

PMID:
1776755
10.

[A precursor of phospholipids in the treatment of severe traumatic comas].

Cohadon F, Richer E, Poletto B.

Neurochirurgie. 1982;28(4):287-90. French.

PMID:
6759958
11.

Efficacy of CDP-choline in the treatment of senile alterations in memory.

de la Morena E.

Ann N Y Acad Sci. 1991;640:233-6.

PMID:
1776744
12.
13.
14.

Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.

Tazaki Y, Sakai F, Otomo E, Kutsuzawa T, Kameyama M, Omae T, Fujishima M, Sakuma A.

Stroke. 1988 Feb;19(2):211-6.

15.

Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases.

Lozano Fernández R.

Arzneimittelforschung. 1983;33(7A):1073-80.

PMID:
6684470
16.

[Respiratory function and alveolar biological changes under the effect of CDP-choline in pulmonary interstitial pathology: pulmonary fibrosis and sarcoidosis].

Pacheco Y, Douss T, Pujol B, Revol A, Vergnon JM, Biot N, Brune J, Perrin-Fayolle M.

Rev Pneumol Clin. 1985;41(2):91-100. French.

PMID:
3839593
17.

[Effect of CDP-choline on senile mental deterioration. Multicenter experience on 237 cases].

Serra F, Diaspri GP, Gasbarrini A, Giancane S, Rimondi A, Tamè MR, Sakellaridis E, Bernardi M, Gasbarrini G.

Minerva Med. 1990 Jun;81(6):465-70. Italian.

PMID:
2193245
18.

Effect of oral CDP-choline on visual function in young amblyopic patients.

Fresina M, Dickmann A, Salerni A, De Gregorio F, Campos EC.

Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):143-50. Epub 2007 Jul 19.

PMID:
17638004
19.

[CDP-choline improves the postoperative rehabilitation of patients with cerebral risk].

Bricourt MO, Ghnassia MD, Legout-Montdargent V.

Agressologie. 1990;31(7):457-63. French.

PMID:
2088110
20.

[Effects of CDP-choline on dynamic changes in LCBF and cognitive function in demented subjects--an H2 15O-PET study].

Tanaka Y, Minematsu K, Hirano T, Hayashida K, Yamaguchi T.

Rinsho Shinkeigaku. 1994 Sep;34(9):877-81. Japanese.

PMID:
7820960

Supplemental Content

Support Center